Chargement en cours...
Bevacizumab and gastrointestinal bleeding in hereditary hemorrhagic telangiectasia
We report a case of severe, refractory gastrointestinal (GI) bleeding in a patient with hereditary hemorrhagic telangiectasia (HHT) whose massive transfusion dependence was lifted shortly after treatment with bevacizumab, an anti-vascular endothelial growth factor. The patient’s bleeding had been re...
Enregistré dans:
| Publié dans: | World J Gastrointest Surg |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5183923/ https://ncbi.nlm.nih.gov/pubmed/28070235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4240/wjgs.v8.i12.792 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|